Results 241 to 250 of about 156,630 (340)

Anesthetic Management of Cesarean Sections in Parturients with Valvular Heart Disease.

Ann Afr Med
Naik SA, Prabhu KM, Misquith JCR, Mahanta P, Ranjan RK.   +4 more
europepmc   +1 more source

Global, Regional, and National Burden of Valvular Heart Disease, 1990 to 2021. [PDF]

J Am Heart Assoc
Chen QF, Shi S, Wang YF, Shi J, Liu C, Xu T, Ni C, Zhou X, Lin W, Peng Y, Zhou XD.   +10 more
europepmc   +1 more source

Transcatheter Aortic Valve Implantation in a Ross Procedure Patient With Severe Autograft Regurgitation: A Case Report

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Surgical aortic valve replacement (AVR) is the standard treatment for symptomatic severe neo‐aortic regurgitation in Ross patients. The only previous report of a transcatheter aortic valve implantation (TAVI) in a Ross patient required valve‐in‐valve rescue. Thus, this is the first uncomplicated TAVI procedure in a Ross patient.
Anindya Mukherjee, Nikhil Joshi, Stephanie Curtis, Mark Turner   +3 more
wiley   +1 more source

Bleeding in valvular heart disease: is von Willebrand factor the culprit? [PDF]

Res Pract Thromb Haemost
Bakhtari S, Vincent F, Susen S.
europepmc   +1 more source

Perventricular Device Closure of Native Congenital Muscular Ventricular Septal Defects in Small Infants   $\hspace{0.17em}$ ≤ 5 kg: Single‐Center Study of the Risk Factors for Failure of the Intervention and Non‐Optimal Outcome

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background and Aims Perventricular device closure of muscular VSD in small infants is a less invasive option than surgical closure under cardiopulmonary bypass and offers better outcomes than palliative pulmonary artery banding. However, the specific risk factors that could affect procedural success and optimal outcomes have not been ...
Emine Hekim Yilmaz, Ilker Kemal Yucel, Murat Surucu, Huseyin Karadag, Ibrahim Halil Demir, Murat Cicek, Numan Ali Aydemir, Ahmet Celebi   +7 more
wiley   +1 more source

Optimizing Anticoagulation in Valvular Heart Disease: Navigating NOACs and VKAs. [PDF]

J Pers Med
Ouatu A, Buliga-Finiș ON, Tanase DM, Badescu MC, Dima N, Floria M, Popescu D, Richter P, Rezus C.   +8 more
europepmc   +1 more source

Percutaneous Ultrasound‐Guided Closure of Perimembranous Ventricular Septal Defects in Children Using Bioabsorbable Occluders—Feasibility and 1‐Year Follow‐Up

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background To reduce complications associated with metal occluders, bioabsorbable occluders have been implanted for perimembranous ventricular septal defects (VSDs) via transthoracic approach. This study investigates the feasibility of echocardiography‐guided percutaneous closure of perimembranous VSDs in children using bioabsorbable occluders,
Liu Liu Huang, Mai Chen, De Cai Zeng, Chun Lan Jiang, Guo Xing Ling, Chun Xiao Su, Bao Shi Zheng, Ji Wu   +7 more
wiley   +1 more source

Safety and efficacy of empagliflozin in heart failure among patients with a history of valvular heart disease: Insights from EMPEROR-Pooled. [PDF]

JTCVS Open
Dhingra NK, Nwajei E, Verma R, Pfarr E, Gasior T, Verma S.   +5 more
europepmc   +1 more source

Minimum Lumen Area Indexed to Left Ventricular Mass to Identify Functionally Significant Left Main Coronary Stenoses

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background and Aim Diagnosing significant left main coronary artery (LMCA) stenoses based on anatomical criteria remains challenging. The ARMYDA FINISH multicenter study evaluated whether indexing intravascular ultrasound (IVUS)‐derived minimum lumen area (MLA) provides greater diagnostic accuracy than unindexed MLA for detecting ...
Giuseppe Patti, Leonardo Grisafi, Marco Mennuni, Luca Cumitini, Manuel Bosco, Domenico D'Amario, Martina Solli, Roberta Rosso, Matilde Villa, Gioel Gabrio Secco, Edoardo Elia, Giuseppe Colonna, Vincenzo Galiffa   +12 more
wiley   +1 more source

Serial Changes in Right Ventricular Outflow Tract Gradient and Endocarditis Risk After Transcatheter Pulmonary Valve Replacement

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Infective endocarditis (IE) after transcatheter pulmonary valve replacement (TPVR) remains a significant concern. Although there are overall good short‐term and long‐term hemodynamic outcomes, limited data exist comparing postimplantation echocardiographic findings leading to IE.
Juan C. Samayoa, Lauren Carlozzi, Connie Choi, William Tressel, Jack M. Wolf, Benjamin Langworthy, Agustin Rubio, Troy Johnston, Zachary L. Steinberg, Thomas Jones, Brian Morray   +10 more
wiley   +1 more source